Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

CFO Steps Down at BG Group plc (ADR) (BRGYY)

LONDON — BG Group plc (ADR) (OTCBB:BRGYY) today announced that CFO Fabio Barbosa will be stepping down after being on medical leave since September and has decided to take a lesser role with the company, presumably to aid in his recovery.

Until a successor is appointed, the responsibilities of the CFO will be handled by Den Jones, who stepped in as an interim director during Barbosa’s leave. Jones has been with BG since 2000 and has 25 years’ experience in the trenches of corporate finance — and all that experience will be needed.

BG Group plc

BG’s shares fell out of favor with the market last year when the company said it expected no growth in production this year. For all the promise that the company’s major projects — the massive gas reserves off Brazil’s coast and the Queensland Curtis Liquid Natural Gas (QCLNG) plant in Australia — hold, shareholders are becoming a bit anxious.

The QCLNG project has suffered from significant cost overruns — the final cost estimate has risen to $20.4 billion from an initial estimate of $15 billion — and Brazil’s offshore reserves are proving trickier to exploit than many had suspected.

To fund these promising prospects, BG has been involved in selling off assets and wrangling up new financing deals — tasks that fall to the CFO and his team. The market appears to be waiting for BG to prove it can deliver on its promise, and being able to successfully maneuver the company’s financials through this expensive period in the company’s operations will be important to that delivery. Jones is being promoted at a critical time for the company but he isn’t exactly new to the situation, which should provide shareholders some comfort.

BG Group is trading on a price-to-earnings ratio of 19, well above the market average, but if it succeeds in bringing QCLNG and its Brazilian assets into production without further cost issues, then BG will likely see dramatic growth in production and cash flow, which could make the current multiple look like a steal. While there is quite a distance between here and there, those growth prospects are certainly tantalizing.

The article CFO Steps Down at BG Group originally appeared on and is written by Nate Weisshaar.

Nate Weisshaar has no position in any stocks mentioned, and neither does The Motley Fool.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!